Treatment of hot flushes in Asian women with ultra-low dose estradiol patch
150 postmenopausal Asian women with vasomotor symptoms, after fulfilling the inclusion and exclusion criteria will be enrolled in the study. The women will be randomly assigned to one of two treatment groups (Menostar® or placebo), after which they will be asked to use a patch once a week for 12 weeks.
- Evidence of postmenopausal status
- Contraindication to estrogen therapy
A multicenter, double-blind, randomized, placebo controlled study on the effect of ultra-low dose transdermal estradiol (Menostar®) on the incidence and severity of hot flushes, other menopausal symptoms and on well-being in postmenopausal Asian women over 12 weeks.